The pharmaceutical landscape for metabolic diseases has reached a pivotal inflection point, marked by the recent approval of the first…
Read More
How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director
The United States, long an outlier in global pharmaceutical pricing, is undergoing a profound transformation in its drug cost landscape,…
Read More
Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business
More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…
Read More
PharmSci 360 2026 heads to New Orleans this October
The American Association of Pharmaceutical Scientists (AAPS) is set to convene its premier annual gathering, PharmSci 360, from October 25…
Read More
Moderna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
At its recent annual Science Day, biotechnology giant Moderna signaled a profound strategic expansion beyond its highly successful infectious disease…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions worldwide, the diagnosis of actinic keratosis (AK) marks the beginning of a challenging journey to prevent skin cancer.…
Read More
A GLP-1 bone study shows why matching matters in real-world evidence
The growing reliance on real-world evidence (RWE) to inform critical healthcare decisions necessitates an unwavering commitment to methodological rigor, a…
Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
A significant shift is underway in the landscape of small-molecule drug discovery, as a new collaborative platform seeks to revolutionize…
Read More
WTWH Media Rebrands to Arrowfly, Signaling Strategic Evolution in B2B Information and Events Landscape
Cleveland-based WTWH Media, a prominent and diversified entity within the business-to-business (B2B) media and events sector, officially announced its corporate…
Read More
Blazing new paths for biotech
For the past several years, success has grown more elusive for American biotech firms, navigating a dramatically altered landscape that…
Read More
